Question 1

How many shares of CVKD does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 1,112 shares of CVKD (CADRENAL THERAPEUTICS INC).

Question 2

What is UBS Group AG's CVKD position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's CVKD position is worth $3,714.

Question 3

Is UBS Group AG buying or selling CVKD?

Accepted Answer

In 2026-Q2, UBS Group AG increased their CVKD position (+370x change in shares).

Question 4

When did UBS Group AG first buy CVKD?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in CVKD in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1,112	+370x	$3,714	0.0%	$3.34	15
2026-Q1	Decreased	3	-99.7%	$15	0.0%	$8.13	0
2025-Q4	Increased	1,044	+2882.9%	$7,078	0.0%	$6.62	18
2025-Q3	Decreased	35	-89.3%	$484	0.0%	$13.42	0
2025-Q2	Decreased	326	-96.1%	$3,928	0.0%	$10.44	0
2025-Q1	Increased	8,445	+288.8%	$148,885	0.0%	$18.46	25
2024-Q4	New	2,172	-	$31,472	0.0%	$14.23	30

CVKD7 quarters

CVKD
7 quarters